PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 3, 20260 citations

Incidence of primary progressive aphasia in Salento, Italy: a population-based study.

View Full Paper
DUDaniele UrsoAVAlessandra VitulliSGStefano Giannoni-Luza

Key Points

  • To assess the population-based incidence of primary progressive aphasia (PPA) in Salento, Italy, and explore related Alzheimer's disease (AD) biomarker profiles.
  • Conducted a 4-year prospective, population-based study in Salento, Italy.
  • Identified incident PPA cases through a territory-wide surveillance network with clinical diagnoses following consensus criteria.
  • Defined AD pathology using positive cerebrospinal fluid or amyloid PET biomarkers.
  • Identified 35 incident PPA cases with an incidence of 1.14 per 100,000 person-years (95% CI, 0.79-1.59).
  • Incidence peaked in early 60s for men and late 70s for women.
  • The logopenic variant was most frequent and associated with AD pathology, with approximately 20% of nonfluent and semantic cases also showing AD biomarkers.

Abstract

INTRODUCTION: Data on the population-based incidence of primary progressive aphasia (PPA), including all variants and Alzheimer's disease (AD) biomarker profiles, are scarce. METHODS: We conducted a 4-year, prospective, population-based study in the Salento region of Southern Italy, identifying incident PPA cases through a territory-wide surveillance network. Clinical diagnoses followed consensus criteria; AD pathology was defined by positive CSF or amyloid PET biomarkers. RESULTS: We identified 35 incident PPA cases, yielding an overall incidence of 1.14 (95% CI, 0.79-1.59) per 100,000 person-years. Incidence peaked in the early 60s for men and in the late 70s for women. The logopenic variant was most frequent and invariably associated with AD pathology. Approximately 20% of nonfluent and semantic cases, and the majority unclassified cases, also showed AD biomarkers. DISCUSSION: These findings provide real-world epidemiological evidence and underscore the need for systematic biomarker assessment in PPA to guide diagnosis, prognosis, and access to emerging therapies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Urso et al. (2026) studied this question.

synapsesocial.com/papers/69f6e5f38071d4f1bdfc699bhttps://doi.org/10.1186/s13195-026-02046-z
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Primary progressive aphasia in Italian and English: a cross-linguistic cohort study2024
  2. 2Clinicoradiological and neuropathological evaluation of primary progressive aphasia2024 · 4 citations
  3. 3Mixed primary progressive aphasia and alcohol use disorder: a case of detailed clinical phenotyping outperforming molecular imaging2026 · 1 citations
  4. 4Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia2026
  5. 5Clinical and Linguistic Profiles and Challenges in Diagnosis of Primary Progressive Aphasia in Medan, Indonesia: A Hospital-based Study2024 · 3 citations